Comparison of pulmonary function tests (PFTs) and 6-minute walk test (6MWT) in patients with lymphangioleiomyomatosis (LAM)

R. Diesler (Bron, France), V. Cottin (Bron, France), S. Turquier (Bron, France), M. Nasser (Bron, France), K. Ahmad (Bron, France), J. Traclet (Bron, France), J. Glerant (Bron, France)

Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Diesler (Bron, France), V. Cottin (Bron, France), S. Turquier (Bron, France), M. Nasser (Bron, France), K. Ahmad (Bron, France), J. Traclet (Bron, France), J. Glerant (Bron, France). Comparison of pulmonary function tests (PFTs) and 6-minute walk test (6MWT) in patients with lymphangioleiomyomatosis (LAM). 3400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015

6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Relationship between six-minute walk test and resting lung function in patients with IPF
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

6-minute walking test (6MWT) in patients with silicosis
Source: Annual Congress 2013 –Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis
Year: 2013


Comparison of 6-minute walk test and shuttle walk test in patients with interstitial lung diseases
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010

The influence of selected sociodemographic parameters on the results of 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 243s
Year: 2004

Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


The six-minute walk test in cystic fibrosis: a comparison to lung function
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009

The six-minute walk test as a measure of exercise capacity in patients cured for pulmonary tuberculosis
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012

Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Six-minute walk test: Comparison with cardiopulmonary exercise test performance, lung function and arterial blood gases in patients with bronchiectasis
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011


Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with sarcoidosis – test of a new approach
Source: Eur Respir J 2007; 30: Suppl. 51, 117s
Year: 2007

Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

Echocardiographic findings in severe chronic obstructive pulmonary disease (COPD) patients who desaturate during 6-minute walking test (6MWT)
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011


Effect of formoterol addition on dynamic hyperinflation during 6-minute walk test (6MWT) in moderate to severe COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Correlation of a modified shuttle walk with six-minute walk test in COPD patients
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018

Multivariables added to walked distance during 6-min walk test (6MWT) can predict the maximal oxigen consumption (Vo2max) in end-stage renal disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 405s
Year: 2004

Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Physiological responses to the 6-minute walk test in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 110s
Year: 2005